|
|
|
Dyslexia Global Clinical Trials Review, H1, 2013
4/12/2013 | published by: GlobalData
Dyslexia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Dyslexia Global Clinical Trials Review, H1, 2013 provides data on the Dyslexia clinical trial scenario. This report provides elemental information and data relating to the
|
read more...
|
$2,500.00
|
|
Psychiatric Disorders – Pipeline Review, H1 2013
4/17/2013 | published by: Global Markets Direct
Psychiatric Disorders – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Psychiatric Disorders - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Psychiatric Disorders,
|
read more...
|
$2,500.00
|
|
Brain Cancer Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
Brain Cancer Drug Pipeline Update 2013 Despite the heavy investment made into brain cancer research, primary brain cancer, with glioblastoma multiforme being the most aggressive and most common form, remains one of the most deadly diseases
|
read more...
|
$5,621.25
|
|
Partial Seizure – Pipeline Review, H1 2013
4/17/2013 | published by: Global Markets Direct
Partial Seizure – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Partial Seizure - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Partial Seizure,
|
read more...
|
$2,000.00
|
|
Memory Impairment – Pipeline Review, H1 2013
4/17/2013 | published by: Global Markets Direct
Memory Impairment – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Memory Impairment - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Memory Impairment,
|
read more...
|
$2,000.00
|
|
Anorexia Nervosa Global Clinical Trials Review, H1, 2013
4/22/2013 | published by: GlobalData
Anorexia Nervosa Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Anorexia Nervosa Global Clinical Trials Review, H1, 2013 provides data on the Anorexia Nervosa clinical trial scenario. This report provides elemental information and data
|
read more...
|
$2,500.00
|
|
Global Deep Brain Stimulator Market 2012-2016
4/26/2013 | published by: Infiniti Research Limited
Global Deep Brain Stimulator Market 2012-2016
TechNavio's analysts forecast the Global Deep Brain Stimulator market to grow at a CAGR of 16.99 percent over the period 2012-2016. One of the
|
read more...
|
$2,000.00
|
|
Disruptive Behavior Disorder – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Disruptive Behavior Disorder – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Disruptive Behavior Disorder - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
read more...
|
$2,000.00
|
|
Motor Neurone Diseases – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Motor Neurone Diseases – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Motor Neurone Diseases - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
read more...
|
$2,000.00
|
|
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets
5/1/2013 | published by: BCC Research
This report provides:
An overview of the global market for Alzheimer's disease therapeutic and diagnostic technologies
Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth
|
read more...
|
$5,450.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
CNS/Neurology Reports